The 20 Best Castleman Disease Doctors in New Jersey, US

David Sokol is a Hematologist and an Oncologist in Plainsboro, New Jersey. Dr. Sokol is rated as an Advanced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Non-Hodgkin Lymphoma, Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, Testicular Yolk Sac Tumor, and Bone Marrow Aspiration. Dr. Sokol is currently accepting new patients.

Dr. Charles Farber is a board-certified, fellowship-trained oncologist at Atlantic Hematology Oncology located at Morristown Medical Center’s Carol G. Simon Cancer Center. He maintains a broad-based practice, yet focuses on benign and malignant hematology. Dr. Farber also serves as medical director of Oncology Research Network Development for Atlantic Health System. In this role, he works with the system’s Breakthrough Oncology Accelerator partners, Translational Genomics Research Institute (TGen) and OriginCV, to expand cancer research at Morristown Medical Center and throughout Atlantic Health System. This partnership ensures that patients have access to the newest and most exciting drugs and technologies through clinical trials. In addition to receiving multiple Patient’s Choice Awards, Dr. Farber has been recognized as a Top Doctor in the New York Metro Area, and listed in Inside Jersey magazine’s Top Doctors, and Consumers Research Council’s Guide to America’s Top Oncologists. He is regarded by colleagues and patients as a knowledgeable, compassionate and devoted physician and has been providing expert care to the Morristown community for more than 20 years. Dr. Farber attended New York University School of Medicine for his medical degree and performed his residency and fellowship at Weill Cornell Medical Center. He also earned a master’s degree and PhD from New York University’s Graduate School of Arts and Sciences. Dr. Farber chairs Morristown Medical Center’s cancer subcommittee for adolescents and young adults and serves as secretary and treasurer of the Oncology Society of New Jersey. He was former chief of the division of Hematology/Oncology at Morristown Medical Center from 2007 to 2011. Dr. Farber serves as a clinical assistant professor at Rutgers and at the Cancer Institute of New Jersey. His research has been published in the Journal of the American Nutraceutical Association, the New England Journal of Medicine and the National Cancer Institute’s Clinical Trial Directory. Dr. Farber is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration.

Andrew Iskandar is a Hematologist and a Hematologist Oncology provider in Sewell, New Jersey. Dr. Iskandar has been practicing medicine for over 10 years and is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Multicentric Castleman Disease (MCD), Lymphoid Hyperplasia, Castleman Disease, and Autoimmune Hemolytic Anemia. Dr. Iskandar is currently accepting new patients.

Triple board-certified in internal medicine, hematology and medical oncology, Dr. Mohamad Cherry is medical director of Hematology at Atlantic Health System. He joins Atlantic Hematology Oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center, bringing years of clinical knowledge and expertise.With specialty training from some of the nation's most skilled clinicians, Dr. Cherry attained some of his clinical training at the leukemia department at MD Anderson and his fellowship in hematology/oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He performed two residencies - an internal medicine residency at Staten Island University Hospital and a laboratory medicine residency at the American University of Beirut Medical Center in Lebanon. Previously, Dr. Cherry attained his medical degree at Lebanese University and performed his internship at Sacre Coeur Hospital-Lebanese University. He also earned a master of science degree in clinical and translational research from University of Oklahoma College of Public Health.Dr. Cherry remains on staff as clinical associate professor of hematology/oncology at University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He is also the director of its hematology/oncology fellowship program and co-chairs the Academy of Teaching Scholars Faculty Development, Education and Mentoring Committee. Other administrative roles include co-chair of the leukemia working group at the Sarah Cannon Research Institute Blood Cancer Consortium.As a principal investigator of multiple clinical trials, Dr. Cherry has performed groundbreaking research in niche areas that include epigenetics and development of new therapeutics in relapsed and refractory blood cancers. He has developed teaching materials and book chapters, and has lectured both nationally and internationally.Dr. Cherry continues to serves as a mentor and an advisor to fellows, residents and medical students. He contributes to continuing education, public health, and professional development, and has won awards and funding for both his research and his clinical pursuits. Dr. Cherry is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Acute Myeloblastic Leukemia without Maturation, Midline Lethal Granuloma, and Bone Marrow Aspiration.

Dr. Markowski has been contributing to the field of oncology since working in a cancer research lab during and after his undergraduate work at Johns Hopkins University. A desire to care for patients brought him back to his home state of New Jersey where he completed his medical school degree at Rutgers-Robert Wood Johnson Hospital in New Brunswick, NJ. He then completed internal medicine residency and subsequent hematology/oncology fellowship training at Rutgers-Robert Wood Johnson Hospital/Cancer Institute of New Jersey.Throughout his hematology and oncology career Dr Markowski has published and presented many peer-reviewed articles, abstracts, and posters on a multitude of cancer types. He has particular interest and expertise in lung cancer, gastrointestinal cancers, and breast cancer. In addition, he has extensive experience taking care of patients with both benign and malignant blood disorders. Dr. Markowski is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Thrombocytopenia, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, and Bone Marrow Aspiration.

Dr. Michael Scola is a board-certified, fellowship-trained hematologist oncologist practicing at Atlantic Hematology Oncology located at Morristown Medical Center. For the past 20 years, Dr. Scola has maintained a broad-based clinical practice, with a focus on benign and malignant hematology. He is currently director of the new Atlantic Thrombosis Center, designed to investigate and manage patients with a variety of bleeding and clotting disorders. Dr. Scola is a skilled and compassionate physician. His postdoctoral training includes a fellowship in hematology oncology from Boston University Medical Center, where he received the Outstanding Fellow award and the Chiefs’ Hematology Award for clinical excellence. He received his medical degree from Baylor College of Medicine in Houston, TX. A teacher and mentor, Dr. Scola served many years as course director of pathophysiology at Northeastern University, Boston, and is actively involved in instructing residents at Morristown Medical Center. He is also involved in clinical research; has worked within the industry as a consultant, lecturer and advisor; and has authored articles and book chapters. Dr. Scola’s education includes a year spent abroad in Florence, Italy, and an intensive post-training program in clinical research at the Harvard School of Public Health. He serves on the boards of the Cancer Hope Network, and the Cancer Support Community of Central New Jersey. Dr. Scola is a member of the American Society of Hematology, American Society of Clinical Oncology and the International Society of Thrombosis and Hemostasis. Dr. Scola is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, Non-Hodgkin Lymphoma, Anemia, and Bone Marrow Aspiration.

Dr. Emmanuel Apor's desire to take care of people channeled him into the field of medicine - specifically into cancer care. Board certified in internal medicine with fellowship training in hematology-oncology, Dr. Apor strives to first understand who his patients are as people, then learn about their disease.While attaining his bachelors of art degree at Rutgers University, Dr. Apor worked at a local hospital which cemented his decision to pursue postgraduate training. He achieved his medical degree at Drexel University College of Medicine in Philadelphia and his residency at the Warren Alpert Medical School at Brown University, where he developed a passion for clinical care working with his general internist mentors and their patients.Dr. Apor attained his fellowship training in hematology-oncology at Brown University, where he served in teaching and research roles, and he held hospital appointments at both Providence Veterans Affairs Medical Center and Rhode Island Hospital. Dr. Apor is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Thrombocytopenia, Familial Colorectal Cancer, and Bone Marrow Aspiration.

Ashish Ashvin Shah, DO, MSc, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in medical oncology and hematology by the American Board of Internal Medicine, he has more than 15 years of experience treating blood diseases and various forms of cancer. Dr. Shah’s clinical interests span a wide spectrum, from acute and chronic leukemia to lymphoma, multiple myeloma, myelodysplastic disease, and various types of cancer, including lung, colorectal, breast, ovarian, and neuroendocrine tumors. He has extensive knowledge and experience in these conditions.After earning his osteopathic medicine degree from Philadelphia College of Osteopathic Medicine, Dr. Shah completed an internal medicine residency at Robert Wood Johnson University Hospital in New Brunswick, NJ. He completed a hematology and oncology fellowship also at Robert Wood Johnson. Previously, he completed a Master of Science (MSc) degree in neuroscience at Southern Connecticut State University.Prior to joining AMG, Dr. Shah served as director of leukemia/lymphoma services and co-director of the adolescent and young adult oncology program at Lehigh Valley Health Network in Bethlehem, Pennsylvania for seven years. He also served as a clinical assistant professor of medicine at the University of South Florida’s Morsani College of Medicine in Tampa. Dr. Shah joined ACOHA in 2016.Dr. Shah is a member of the American Society of Clinical Oncology, American Society of Hematology, American Osteopathic Association, and American Association of Physicians from India. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Iron Deficiency Anemia, Large-Cell Immunoblastic Lymphoma, Childhood Iron Deficiency Anemia, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Richard Greenberg is a Hematologist and an Oncologist in Voorhees, New Jersey. Dr. Greenberg is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Iron Deficiency Anemia. Dr. Greenberg is currently accepting new patients.

Sheetal Shrimanker is a Hematologist and an Oncologist in Plainsboro, New Jersey. Dr. Shrimanker is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Multiple Myeloma, Pancreatic Cancer, Familial Pancreatic Cancer, and Non-Hodgkin Lymphoma. Dr. Shrimanker is currently accepting new patients.

Lori Leslie is an Oncologist and a Hematologist in Hackensack, New Jersey. Dr. Leslie is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, Mantle Cell Lymphoma (MCL), Bone Marrow Aspiration, and Lymphadenectomy.

Michele Donato is an Oncologist and a Hematologist in Hackensack, New Jersey. Dr. Donato is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Multiple Myeloma, Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Colonoscopy.

Kelly Fitzpatrick is an Oncologist and a Hematologist in Hackensack, New Jersey. Dr. Fitzpatrick is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Primary Mediastinal B-Cell Lymphoma (PMBCL), Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Hereditary Resistance to Anti-Vitamin K, and Bone Marrow Aspiration.

Dr. Sonyo Shin is an esteemed attending hematologist/oncologist at Advanced Care Oncology and Hematology Associates (ACOHA), a distinguished part of Atlantic Medical Group (AMG). With over 20 years of dedicated experience in the field, she is deeply committed to delivering patient-centered care in both hematology and oncology.Dr. Shin is board-certified in internal medicine, oncology, and hematology by the American Board of Internal Medicine. Her extensive expertise encompasses the treatment of a wide range of malignancies, including lymphoma, lung cancer, and chronic leukemia. She has been instrumental in developing and leading multidisciplinary breast cancer clinics, ensuring a comprehensive approach to patient care.In addition to her clinical practice, Dr. Shin is actively involved in clinical trials, contributing to the advancement of cancer research. She is also passionate about education, mentoring medical residents and students to foster the next generation of healthcare professionals. Her commitment to excellence in patient care and education underscores her role as a leader in the field of hematology and oncology. Dr. Shin is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Paget Disease of the Breast, Familial Colorectal Cancer, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.

William Derosa is a Hematologist and an Oncologist in Morristown, New Jersey. Dr. Derosa is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Plasmacytoma, Small Lymphocytic Lymphoma (SLL), Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, and Bone Marrow Aspiration. Dr. Derosa is currently accepting new patients.

Mahmoud Aly is a Hematologist and an Oncologist in Hazlet, New Jersey. Dr. Aly is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Myeloproliferative Neoplasms (MPN), Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, and Vitamin B12 Deficiency.

Jose Bustillo is a primary care provider, practicing in Internal Medicine in Newark, New Jersey. Dr. Bustillo is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, and Lung Cancer. Dr. Bustillo is currently accepting new patients.

Beiqing Pan is an Internal Medicine provider in Edison, New Jersey. Dr. Pan is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Familial Colorectal Cancer, Paget Disease of the Breast, Metastatic Pleural Tumor, and Mediastinal Tumor.

Michael Mauro is a Hematologist in Montvale, New Jersey. Dr. Mauro is rated as an Advanced provider by MediFind in the treatment of Castleman Disease. His top areas of expertise are Chronic Myelogenous Leukemia (CML), Leukemia, Myeloproliferative Neoplasms (MPN), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Mauro is currently accepting new patients.

Christina Clay is a Hematologist and a General Surgeon in Camden, New Jersey. Dr. Clay has been practicing medicine for over 41 years and is rated as an Experienced provider by MediFind in the treatment of Castleman Disease. Her top areas of expertise are Sickle Cell Disease, Paget Disease of the Breast, Breast Cancer, Childhood Iron Deficiency Anemia, and Vertebroplasty.